Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Multicenter, Phase III Study to Evaluate the Immunogenicity and Safety of 'MG1109(Egg-based, Pre-pandemic Influenza(H5N1) Vaccine)' Administered Intramuscularly in Healthy Adult Volunteers

NCT01987011 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01987011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01987011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Multicenter, Phase III Study to Evaluate the Immunogenicity and Safety of 'MG1109(Egg-based, Pre-pandemic Influenza(H5N1) Vaccine)' Administered Intramuscularly in Healthy Adult Volunteers
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2013
Completion date
March 31, 2014
Enrollment
420 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza